Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
2017-N-05
Funder:
National Natural Science Foundation of China
Topic:
Diabetes Treatment and Management
Subfield:
Endocrinology, Diabetes and Metabolism
Field:
Medicine
Domain:
Health Sciences
Funded outputs count:
3
Funder award ID:
2017-N-05
OpenAlex ID:
G202709947
Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High‐Fat Diet
2020
·
Ningjing Zhang
, Junxian Tao
, et al.
·
BioMed Research International
·
37
PDF
Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial
2018
·
Ting-Ting Yin
, Yan Bi
, et al.
·
Nutrition & Metabolism
·
31
PDF
Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non‐alcoholic fatty liver disease: A randomized trial
2018
·
Wen‐Huan Feng
, Yan Bi
, et al.
·
Journal of Diabetes Investigation
·
156
PDF
Show more works
View as search